Feedback / Questions
KROS-101 - Kairos Pharma
https://www.businesswire.com/news/home/20250603180931/en/Kairos-Pharma-Ltd.-Announces-New-Data-on-Small-Molecule-GITR-Ligand-Agonist-KROS-101-as-Promising-Cancer-Immunotherapy-at-the-American-Society-of-Clinical-Oncology-ASCO-2025-Annual-Meeting
Jun 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next